TCRX - TScan Therapeutics, Inc. Quarterly EPS earnings growth
Investments in the expert T-cell target discovery staff at TScan Therapeutics (TCRX) are driving the company's development, as reflected in the GURU.Markets terminal by a quarterly EPS growth vector, where the value 17.70 represents the most recent figure. The proprietary ecosystem of TScan Therapeutics creates a dependency among pharma behemoths on its licenses, while the successful completion of clinical trials will provide powerful pricing power within the personalized oncology segment.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_TCRX_-_TScan-Therapeutics_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "TScan (TCRX): Year-over-year net earnings per share growth for the last 12 months from 07/04/2022 to 11/12/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company TScan Therapeutics (TCRX)
- market value and analyst target forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital TScan Therapeutics|TCRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital tscan.com|TCRX - Company Aggregate Debts|Debt to Book Capitalization Ratio TScan|TCRX - Company Long-Term Indebtedness|Company Current Liabilities TScan Therapeutics|Quick Liquidity Indicator tscan.com
- earnings and valuation multiples information:
TCRX - Profit After Payment of Taxes|Projected Future Earnings TScan Therapeutics|TCRX - Company Value to Net Income|Forward P/E Multiple tscan.com|TCRX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TScan|TCRX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) TScan Therapeutics|TCRX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months tscan.com|TCRX - Earnings per share trend in current year|Earnings growth forecast for next year TScan Therapeutics
Initial company analysis:TScan Therapeutics
Quarterly earnings per share (EPS) dynamics allow investors to filter out market noise and assess the actual efficiency of business capitalization through the lens of net income. By analyzing the trend of quarterly EPS growth, an investor can correlate the financial stability of TScan Therapeutics (TCRX) with its progress in developing T-cell cancer therapies, which determines the company's long-term fundamental value.
Key competitors
BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Year-over-year net earnings per share growth for the last 12 months CGON (CG Oncology, Inc.)|Year-over-year earnings per share growth rate for the last twelve months URGN|Year-over-year earnings per share growth for the last twelve months Bicara Therapeutics BCAX|Year-over-year net earnings per share change for the last twelve months Personalis Inc (PSNL)|Erasca Corp - Quarterly EPS earnings growth|Delcath Corp (DCTH) - Year-over-year net earnings per share growth for the last 12 months|YMAB: Quarterly EPS earnings growth|aurabiosciences.com (AURA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Candel Therapeutics Inc.|Year-over-year earnings per share growth for the last 12 months ARAY (Accuray Inc)|Year-over-year net earnings per share growth for the last 12 months SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics Inc) - Year-over-year earnings per one share growth for the last 12 months|Citius Oncology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months HURA (TuHURA Biosciences Inc.)|Protara Therapeutics, Inc. - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months FATE (Fate Therapeutics Inc)|WHWK: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Champions Oncology, Inc. (CSBR)|Year-over-year earnings per share growth for the last twelve months XBiotech Inc|CVM: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth OSTX|Quarterly EPS earnings growth Radiopharm Theranostics Ltd (RADX)|Year-over-year earnings per share growth for the last twelve months Artiva Biotherapeutics ARTV|ANL (Adlai Nortye Ltd) - Year-over-year net earnings per share trend for the last twelve months|Veru Inc. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months tempesttx.com|XLO (xiliotx.com) - Year-over-year net earnings per share growth for the last 12 months|Renovaro (RENB) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months MURA|KAPA (Kairos Pharma Inc) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth OKUR|Year-over-year net earnings per share change for the last twelve months w2.cytomed.sg|Quarterly EPS earnings growth CRIS (Curis)|APLM - Year-over-year net earnings per share growth for the last 12 months|THAR - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Advanced Biomed Inc ADVB|GNPX (Genprex, Inc.) - Year-over-year net earnings per share growth for the last 12 months|CLDI: Year-over-year earnings per share growth rate for the last twelve months|SBFM (Sunshine Biopharma) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Xenetic Bio (XBIO)|Year-over-year earnings per share growth for the last twelve months Salarius (SLRX)|PPBT (Kitov Pharma) - Year-over-year earnings per one share growth for the last 12 months|American Oncology Network, Inc. - Year-over-year net earnings per share growth for the last 12 months|BGNE: Year-over-year earnings per share growth for the last 12 months|Checkpoint Therapeutics, Inc. - Quarterly EPS earnings growth|Elevation Oncology Inc. (ELEV) - Year-over-year net earnings per share growth for the last 12 months|ICAD: Quarterly EPS earnings growth|Ikena Oncology (IKNA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Notable Labs, Ltd.|Year-over-year earnings per share growth for the last 12 months VIRX (Viracta)|Quarterly EPS earnings growth MOR|Year-over-year net earnings per share growth for the last 12 months NAYA Biosciences Inc NAYA|Quarterly EPS earnings growth AAPGV (Ascentage Pharma Group Ltd)
